The number of <i>PTEN</i> mutations were low (1/45) in the sporadic breast cancer cases analyzed in the present study and <i>PTEN</i> promoter methylation may have been the main mechanism leading to the decreased expression of <i>PTEN</i>. The gene discussed is PTEN; the disease is breast carcinoma.